This inventor holds 1 USPTO granted patent and 5 published patent applications and 2 EPO patents. Top assignee: Hanmi Pharm. Co., Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovations of Jin Wook Tak
Introduction
Jin Wook Tak is a notable inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of composite formulations. His work is characterized by a focus on innovative solutions that address critical health issues.
Latest Patents
One of Jin Wook Tak's most recent patents is titled "Composite formulation comprising sitagliptin and dapagliflozin and preparation method therefor." This patent provides a composite formulation that includes sitagliptin and dapagliflozin, along with a method for preparing the same. This innovation is aimed at improving treatment options for patients with specific health conditions.
Career Highlights
Jin Wook Tak is currently employed at Hanmi Pharmaceutical Co., Ltd., a leading company in the pharmaceutical industry. His role at Hanmi Pharm allows him to leverage his expertise in drug formulation and development. With a focus on creating effective pharmaceutical solutions, he has established himself as a key player in his field.
Collaborations
Throughout his career, Jin Wook Tak has collaborated with talented professionals, including Bo Sik Kim and Jung Hyun Cho. These collaborations have contributed to the advancement of innovative pharmaceutical products and have fostered a culture of teamwork and creativity within the industry.
Conclusion
Jin Wook Tak's contributions to the pharmaceutical field through his innovative patents and collaborations highlight his commitment to improving healthcare solutions. His work continues to inspire advancements in drug formulation and development.